Rhodes Pharms Company Profile
✉ Email this page to a colleague
What is the competitive landscape for RHODES PHARMS, and what generic and branded alternatives to RHODES PHARMS drugs are available?
RHODES PHARMS has twenty-seven approved drugs.
There are two tentative approvals on RHODES PHARMS drugs.
Drugs and US Patents for Rhodes Pharms
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Rhodes Pharms | DEXTROAMP SACCHARATE, AMP ASPARTATE, DEXTROAMP SULFATE AND AMP SULFATE | amphetamine aspartate; amphetamine sulfate; dextroamphetamine saccharate; dextroamphetamine sulfate | CAPSULE, EXTENDED RELEASE;ORAL | 210651-005 | May 17, 2019 | AB1 | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Rhodes Pharms | METHYLPHENIDATE HYDROCHLORIDE | methylphenidate hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 214111-003 | May 31, 2022 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | |||||
Rhodes Pharms | THEOPHYLLINE | theophylline | TABLET, EXTENDED RELEASE;ORAL | 040086-001 | Apr 15, 1996 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for Rhodes Pharms
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Rhodes Pharms | DILAUDID | hydromorphone hydrochloride | TABLET;ORAL | 019892-003 | Nov 9, 2007 | 6,589,960 | ⤷ Try a Trial |
Rhodes Pharms | APTENSIO XR | methylphenidate hydrochloride | CAPSULE, EXTENDED RELEASE;ORAL | 205831-007 | Apr 17, 2015 | 10,463,624 | ⤷ Try a Trial |
Rhodes Pharms | APTENSIO XR | methylphenidate hydrochloride | CAPSULE, EXTENDED RELEASE;ORAL | 205831-003 | Apr 17, 2015 | 10,463,624 | ⤷ Try a Trial |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Paragraph IV (Patent) Challenges for RHODES PHARMS drugs
Drugname | Dosage | Strength | Tradename | Submissiondate |
---|---|---|---|---|
➤ Subscribe | Extended-release Capsules | 10 mg | ➤ Subscribe | 2015-12-24 |
➤ Subscribe | Extended-release Capsules | 30 mg | ➤ Subscribe | 2016-03-28 |
➤ Subscribe | Injection | 2 mg/mL | ➤ Subscribe | 2011-06-22 |
➤ Subscribe | Extended-release Capsules | 60 mg | ➤ Subscribe | 2015-12-23 |
➤ Subscribe | Extended-release Capsules | 15 mg, 20 mg, 40 mg and 50 mg | ➤ Subscribe | 2015-12-28 |
➤ Subscribe | Oral Solution | 5 mg/5mL | ➤ Subscribe | 2011-02-25 |
➤ Subscribe | Tablets | 2 mg, 4 mg, and 8 mg | ➤ Subscribe | 2013-08-05 |
Similar Applicant Names
Here is a list of applicants with similar names.